Search details
1.
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 107(1): 24-31, 2018.
Article
in English
| MEDLINE | ID: mdl-29518779
2.
BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?
Curr Treat Options Oncol
; 18(2): 9, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28214977
3.
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Acta Oncol
; 55(9-10): 1168-1174, 2016.
Article
in English
| MEDLINE | ID: mdl-27333436
4.
New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
Curr Oncol Rep
; 18(3): 18, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26861657
5.
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenib.
Oncologist
; 19(4): 394-402, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24652387
6.
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection.
Cancer
; 118(20): 4981-90, 2012 Oct 15.
Article
in English
| MEDLINE | ID: mdl-22415897
7.
First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers.
Liver Cancer
; 11(3): 268-277, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35949290
8.
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study.
Cancers (Basel)
; 14(18)2022 Sep 17.
Article
in English
| MEDLINE | ID: mdl-36139669
9.
[Targeted therapies in colorectal cancer]. / Traitements ciblés des cancers colorectaux.
Rev Prat
; 60(8): 1094-9, 2010 Oct 20.
Article
in French
| MEDLINE | ID: mdl-21197741
10.
[New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?]. / Nouvelles classifications moléculaires du cancer colorectal, du cancer du pancréas et du cancer de l'estomac : vers un traitement à la carte ?
Bull Cancer
; 103(7-8): 643-50, 2016.
Article
in French
| MEDLINE | ID: mdl-27345450
11.
Pharmacokinetics and safety of DTS-108, a human oligopeptide bound to SN-38 with an esterase-sensitive cross-linker in patients with advanced malignancies: a Phase I study.
Int J Nanomedicine
; 11: 6207-6216, 2016.
Article
in English
| MEDLINE | ID: mdl-27920527
12.
Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy.
World J Hepatol
; 7(6): 910-5, 2015 Apr 28.
Article
in English
| MEDLINE | ID: mdl-25937868
13.
Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential.
Ther Adv Med Oncol
; 4(1): 9-18, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-22229044
14.
[PI3K-AKT-mTOR pathway and cancer]. / Rôle de la voie PI3K-AKT-mTOR dans le cancer et les thérapeutiques antitumorales.
Bull Cancer
; 99(2): 173-80, 2012 Feb 01.
Article
in French
| MEDLINE | ID: mdl-21742593
15.
Sunitinib in pancreatic neuroendocrine tumors.
Target Oncol
; 7(2): 117-25, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22661319
16.
Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib.
Target Oncol
; 7(2): 127-33, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22585430
17.
Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
Medicine (Baltimore)
; 91(6): 309-318, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23117849
18.
Gemcitabine in elderly patients with advanced pancreatic cancer.
World J Gastroenterol
; 17(30): 3497-502, 2011 Aug 14.
Article
in English
| MEDLINE | ID: mdl-21941416
19.
Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors.
Target Oncol
; 6(2): 119-24, 2011 Jun.
Article
in English
| MEDLINE | ID: mdl-21533544
20.
Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib.
Clin Cancer Res
; 17(13): 4504-12, 2011 Jul 01.
Article
in English
| MEDLINE | ID: mdl-21531821